1995
DOI: 10.1172/jci117890
|View full text |Cite
|
Sign up to set email alerts
|

Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia.

Abstract: The pathogeneses of parathyroid disease in patients with uremia and nonfamilial primary parathyroid hyperplasia are poorly understood. Because of multigland involvement, it has been assumed that these common diseases predominantly involve polyclonal (non-neoplastic) cellular proliferations, but an overall assessment of their clonality has not been done. We examined the clonality of these hyperplastic parathyroid tumors using X-chromosome inactivation analysis with the M27,B (DXS255) DNA polymorphism and by sea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
143
2
3

Year Published

1997
1997
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 372 publications
(152 citation statements)
references
References 36 publications
4
143
2
3
Order By: Relevance
“…Seven solitary tumours repeatedly gave ratios suggesting a polyclonal origin. Besides admixture with normal tissue, a pattern suggestive of a polyclonal origin could also result from an aberrant pattern of DNA methylation or the presence of two clonal expansions with opposing X-chromosome inactivation patterns (12). Furthermore, a comparison of two independent methods for the study of X-chromosome inactivation reported con¯icting results in 10% of all cases evaluated (15).…”
Section: Discussionmentioning
confidence: 99%
“…Seven solitary tumours repeatedly gave ratios suggesting a polyclonal origin. Besides admixture with normal tissue, a pattern suggestive of a polyclonal origin could also result from an aberrant pattern of DNA methylation or the presence of two clonal expansions with opposing X-chromosome inactivation patterns (12). Furthermore, a comparison of two independent methods for the study of X-chromosome inactivation reported con¯icting results in 10% of all cases evaluated (15).…”
Section: Discussionmentioning
confidence: 99%
“…Although genomic hybridization and loss of heterozygosity (LOH) studies have suggested the presence of an undiscovered parathyroid tumor suppressor gene on the X chromosome [11,24,25], and notwithstanding that ZFX deletion has led to tumorigenesis in an experimental liver cancer model in mice [26], it does not appear that ZFX is acting as a classic two-hit human tumor suppressor in parathyroid adenomas. In particular, we observed no mutations that would be expected to inactivate the ZFX gene product, such as early stop codons or frameshifts; in addition, none of the female patients' tumor samples that harbored a ZFX mutation showed LOH at the corresponding wild type locus.…”
Section: Discussionmentioning
confidence: 99%
“…In parathyroid cells, a rise in FM1-43 fluorescence occurred during incubation in a high (inhibitory) In patients with primary hyperparathyroidism, secretion of PTH continues uninhibited in the face of hypercalcaemia. Most patients with primary hyperparathyroidism have a single parathyroid adenoma whose cells are monoclonal [8][9][10], have a lower [Ca# + ] i in response to [Ca# + ] ext [11,12] and a higher set point (defined as the [Ca# + ] ext necessary for half-inhibition of PTH secretion) [13]. Cloning of the CaR from bovine parathyroid cells [2] and its isolation from human parathyroid adenomas [4] raised hopes that the molecular basis of primary hyperparathyroidism would be better understood.…”
Section: Introductionmentioning
confidence: 99%